Aitken. R.C.B.: Measurement of feelings using visual analogue scales. Proc. R. Soc. Med. 62: 989-993 (1969).
Ansseau, M.; Doumont, A.; Diricq, S.: Methodology required to show clinical differences between benzodiazepines. Curr. med. Res. Opin. 8: suppl. 4, pp. 108-114 (1984).
Ansseau. M.; Doumont, A.; Thiry. D.; Cerfontaine, J.L.; Tjandramaga, T.B.; Verbesselt, R.; De Schepper, P.J.: Oxazepam bioavailability in healthy male volunteers after single dose (15 mg) oral administration: comparison between freeze-dried dosage (FDD) and tablet formulation (in press).
Bond. A.; Lader, M.: The use of analogue scales in rating subjective feelings. Br. J. med. Psychol. 47: 211-218 (1974).
Cooley. J.W.; Tukey. J.W.: An algorithm for machine calculation of complex Fourier series. Maths Comput. 19: 297-301 (1965).
Detti, I.: Benzodiazepines in the treatment of insomnia: pharmacokinetic considerations; in Costa, The benzodiazepines: from molecular biology to clinical practice, pp. 173-199 (Raven Press. New York 1983).
Fink, M.: Cerebral electrometry - quantitative EEG applied to human psychopharmacology; in Dolce, Kunkel. Computerized EEG analysis, pp. 272-288 (Fisher, Stuttgart 1975).
Fink, M.; Irwin, P.; Weinfeld. R.E.; Schwartz. M.A.; Conney, A.H.: Blood levels and elcctrocncephalographic effects of diazepam and bromazepam. Clin. Pharmacol. Ther. 20: 184-191 (1976).
Freyd, M.: The graphic rating scale. J. educ. Psychol. 14: 83-102 (1923).
Gibbs, F.A.; Gibbs, E.L.: Clinical and pharmacological correlates of fast activity in electroencephalography. J. Neuropsychiat. 3: 573-578 (1962).
Greenblatt, D.J.; Shader, R.I.; Abemethy. D.R.: Current status of benzodiazepines. New Engl. J. Med. 309: 410-416 (1983).
Hamilton, M.: The assessment of anxiety states by ratings. Br. J. med. Psychol. 32: 50-55 (1959).
Herrmann. W.M.; Irrgang, U.: An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitations. Pharmacopsychiat. 16: 134-142 (1983).
Itil, T.M.: Quantitative pharmaco-electroencephalography; in Itil. Modem problems of pharmacopsychiatry, vol. 8. Psychotropic drugs and the human EEG, pp. 43-75 (Karger. Basel 1974).
Kaplan, S.A.; Jack, M.L.: Metabolism of the benzodiazepines: Pharmacokinetic and pharmacodynamic considerations; in Costa, The benzodiazepines: from molecular biology to clinical practice, pp. 173-199 (Raven Press, New York 1983).
Kellner, R.; Uhlenhuth, E.H.; Glass. R.M.: Clinical evaluation of antianxicty agents: subject-own-control designs; in Lipton, Di-Mascio, Killam, Psychopharmacology: a generation of progress, pp. 1391-1400 (Raven Press, New York 1978).
Kurowski. M.; Ott, H.; Herrmann, W.M.: Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lor- metazepam. Pharmacopsychiat. 15: 77-83 (1982).
Lader, M.; Petursson, H.: Rational use of anxiolytic/sedative drugs. Drugs. 25: 514-528 (1983).
Lehmann, D.; Koukkou, M.: Computer analysis of EEG wakefuiness-sleep patterns during learning of novel and familiar sentences. Electroenceph. clin. Neurophysiol. 37: 73-84 (1974).
Marjerrison, G.: Effects of minor tranquilizers on the EEG; in Itil. Modern problems of pharmacopsychiatry, vol. 8. Psychotropic drugs and the human EEG. pp. 149-157 (Karger. Basel 1974).
Matejcek, M.: Pharmaco-electroencephalography: the value of quantified EEG in psychopharmacology. Pharmacopsychiat. 12: 126-136 (1979).
Matejcek, M.; Neff. G.; Abt, K.; Wehrli. W.: Pharmaco-EEG and psychometric study of the effect of single doses of temazepam and nitrazepam. Neuropsychobiology. 9: 52-65 (1983).
Möhler, H.; Richards, J.G.: Benzodiazepine receptors in the central nervous systems; in Costa. The benzodiazepines: from molecular biology to clinical practice, pp. 93-116 (Raven Press. New York 1983).
Saletu, B.; Grünberger, J.: Evaluation of pharmacodynamic properties of psychotropic drugs: quantitative EEG, psychometric and blood level investigations in normals and patients. Pharmacopsychiat. 72:45-58 (1979).
Saletu, B.; Grünberger, J.; Linzmayer. L.; Stadler, R.: Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis. Arz- neimittel-Forsch. 30: 513-518 (1980).
Spiegel, M.R.: Theory and problems of statistics (McGraw-Hill, New York 1972).
Spitzer, R.; Endicott, J.; Robins, E.: Research diagnostic criteria: rationale and reliability. Arch. gen. Psychiat. 34: 773-782 (1978).